Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Norrköping
Clinical trial register · Sweden

Clinical Trials in Norrköping, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Norrköping

23 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
University Hospital, Linkoeping
Not applicable
20
Norrköping
2026-09-01
Recruiting
Treating Emergency Laparotomy Incisions With Negative Pressure Wound Therapy
NCT07003906Surgical Incision, Wound Dehiscence, Surgical Site Infection, Incisional Hernia
Uppsala University
Not applicable
720
Eskilstuna, Linköping, Mora, Norrköping, Uppsala, Västerås
2025-12-16
By invitation
Linkoeping University
Not applicable
120
Gothenburg, Helsingborg, Kalmar, Linköping, Lund, Motala, Norrköping, Västerås
2025-11-20
Recruiting
Linkoeping University
Not applicable
3,000
Finspång, Linköping, Mjölby, Norrköping, Vaxjo
2025-11-04
Active, closed
Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study
NCT07347093Gastric Bypass Surgery, Revisional Bariatric Surgery, Complications After Bariatric Surgery
Vrinnevi Hospital
Observational
199
Norrköping
2025-11-01
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Falun, Gothenburg, Helsingborg, Lund, Norrköping, Solna, Stockholm
2025-06-25
Active, closed
OGTT at Home Using CGM vs at the Clinic
NCT06862128Pre-diabetes, Diabetes
Linkoeping University
Not applicable
70
Huskvarna, Norrköping, Linköping
2025-06-11
Recruiting
AstraZeneca
Phase 3
11,300
Gothenburg, Helsingborg, Huddinge, Lund, Mölndal, Norrköping, Stockholm, Uppsala
2025-03-14
Active, closed
Linkoeping University
Not applicable
12
Norrköping
2025-02-01
Active, closed
The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction
NCT06262815Small Bowel Obstruction, Frailty, Nasogastric Tube
Daniel Wilhelms
Observational
400
Gothenburg, Lund, Malmö, Motala, Norrköping, Sundsvall, Linköping
2024-01-01
Recruiting
Karolinska Institutet
Not applicable
228
Stockholm, Norrköping
2023-11-14
Recruiting
Fluid Challenge and Plasma Volume, During Surgery
NCT05726136Colorectal Cancer, Urologic Cancer, Gynecologic Cancer, Colorectal Disorders
Joachim Zdolsek
Phase 4
60
Norrköping
2023-10-23
Recruiting
Region Jönköping County
Observational
600
Falun, Eksjö, Jönköping, Kalmar, Uppsala, Örebro, Linköping, Norrköping
2023-09-01
Recruiting
Chronic Coronary Syndrome in Swedish Primary Care
NCT05782582Coronary Artery Disease
Region Östergötland
Not applicable
500
Linköping, Norrköping
2023-05-01
Recruiting
Linnaeus University
Not applicable
60
Norrköping
2022-10-03
Recruiting
Linkoeping University
Not applicable
750
Jönköping, Kalmar, Linköping, Norrköping
2022-05-16
Active, closed
RSI Observation Follow-up
NCT05775029RSI, Rapid Sequence Induction, Complication of Anesthesia, Compliant Behavior
Jakob Zeuchner
Observational
2,300
Linköping, Norrköping
2022-05-05
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Falun, Gothenburg, Jönköping, Linköping, Malmö, Norrköping, Örebro, Uppsala
2021-08-14
Active, closed
Myocardial Injury in Noncardiac Surgery in Sweden
NCT03436238Perioperative/Postoperative Complications, Risk Factor, Cardiovascular
Linkoeping University
Observational
1,269
Kristianstad, Eskilstuna, Jönköping, Lund, Malmö, Norrköping, Linköping
2017-05-15
Recruiting
Olof Akre
Not applicable
1,200
Falun, Gothenburg, Helsingborg, Jönköping, Karlskrona, Linköping, Malmö, Norrköping
2014-10
Active, closed
University Hospital, Linkoeping
Not applicable
198
Linköping, Norrköping
2014-09-01
Active, closed
Treatment of Class II Malocclusion With Excessive Overjet
NCT04508322Class II Malocclusion, Division 1, Orthodontic Appliances, Quality of Life, Costs and Cost Analysis
Jenny Kallunki
Not applicable
96
Norrköping
2013-12-05
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Borås, Malmö, Norrköping
1991-04-01
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/norrk-ping

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Norrköping.

How many clinical trials are recruiting in Norrköping?

12 of the 23 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 8 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Norrköping), 23 studies
PhaseStudiesRecruitingShare
Not applicable13756.5%
Observational6226.1%
Phase 33213%
Phase 4114.3%

Most active sponsors

Lead sponsors with the most studies (Norrköping)
Lead sponsorStudiesRecruiting
Linkoeping University62
University Hospital, Linkoeping20
Amgen11
AstraZeneca11
Daniel Wilhelms10
Genzyme, a Sanofi Company11
Jakob Zeuchner10
Jenny Kallunki10
Joachim Zdolsek11
Karolinska Institutet11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.